Immune and behavioral correlates of protection against symptomatic post-vaccination SARS-CoV-2 infection
Goguet E, Olsen C, Meyer W, Ansari S, Powers J, Conner T, Coggins S, Wang W, Wang R, Illinik L, Edwards M, Jackson-Thompson B, Hollis-Perry M, Wang G, Alcorta Y, Wong M, Saunders D, Mohammed R, Balogun B, Kobi P, Kosh L, Bishop-Lilly K, Cer R, Arnold C, Voegtly L, Fitzpatrick M, Luquette A, Malagon F, Ortega O, Parmelee E, Davies J, Lindrose A, Haines-Hull H, Moser M, Samuels E, Rekedal M, Graydon E, Malloy A, Tribble D, Burgess T, Campbell W, Robinson S, Broder C, O’Connell R, Weiss C, Pollett S, Laing E, Mitre E. Immune and behavioral correlates of protection against symptomatic post-vaccination SARS-CoV-2 infection. Frontiers In Immunology 2024, 15: 1287504. PMID: 38566991, PMCID: PMC10985347, DOI: 10.3389/fimmu.2024.1287504.Peer-Reviewed Original ResearchConceptsResearch assaySARS-CoV-2Commercial assaysIgA binding antibodiesCorrelates of protectionAnti-spike IgG levelsSpike-specific IgGShorter duration of illnessDuration of illnessMultivariate regression analysisSARS-CoV-2 infectionShort durationSARS-CoV-2 variantsNeutralization titersPost-vaccination SARS-CoV-2 infectionIgG levelsNeutralizing activityOmicron waveBehavioral correlatesRisk scoreDisease severityBinding antibodiesSerumSaliva samplesOmicron subvariants
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply